They can run with that thought all they want.
Post# of 36514
![](/assets/46931549/no_avatar_available_thumb.jpg)
The fact remains that the capital structure for the NGIO IPO has been adjusted for a realistic, near-term Naz listing, and we have a vaccine that is being worked on with FDA involvement that has progressed to the point that the testing product is in manufacturing with a fill/finish contract in place.
This is no longer some rah rah situation based on hopes and dreams. It doesn't take a genius to read between the lines on the progress that has been made. Some of the "potential" is about to be let loose.
I'm not sure what more one could ask for as we sit under $60MM market cap.
Will be interesting to see what happens as we approach the close.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)